Tripair™ presented by Dr. Paul Sorajja at New York Valves Summit
“Tripair's momentum reflects the strong interest from the structural heart community in innovative, scalable solutions for tricuspid regurgitation”
June 2025
Tripair™ was featured at the Cardiovascular Research Foundation’s New York Valves Summit 2025 during the Innovators Session, where Dr. Paul Sorajja, one of the leading voices in structural heart interventions, presented the technology to an audience of global experts.
NY Valves is a premier annual meeting that brings together physicians, clinical researchers, and industry leaders to exchange insights and showcase the latest innovations in transcatheter therapies. Dr. Sorajja’s presentation highlighted the growing recognition of Tripair™ within the tricuspid repair field and its potential to address one of the largest unmet needs in structural heart disease.
During his talk, Dr. Sorajja introduced Tripair™’s edge-to-spacer repair system, a novel approach designed to simplify tricuspid repair by addressing the current restrictive complexities in the treatment of tricuspid regurgitation. The system’s design aims to reduce procedural complexity, expand accessibility, and offer cost-effectiveness both within the hospital setting and the manufacturing process.
Dr. Sorajja’s involvement underscored Tripair™’s clinical momentum and the strong interest from the structural heart community in innovative, scalable solutions for tricuspid regurgitation.